Literature DB >> 35834759

BRCA2 Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case Series.

Lynn Symonds1, Erik Konnick2, Funda Vakar-Lopez2, Heather H Cheng1,3, Michael T Schweizer1,3, Peter S Nelson1,2,3,4, Colin C Pritchard2,5, Bruce Montgomery1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35834759      PMCID： PMC9307304          DOI： 10.1200/PO.22.00091

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  31 in total

Review 1.  Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Authors:  Miguel A Sanz; Pierre Fenaux; Martin S Tallman; Elihu H Estey; Bob Löwenberg; Tomoki Naoe; Eva Lengfelder; Hartmut Döhner; Alan K Burnett; Sai-Juan Chen; Vikram Mathews; Harry Iland; Eduardo Rego; Hagop Kantarjian; Lionel Adès; Giuseppe Avvisati; Pau Montesinos; Uwe Platzbecker; Farhad Ravandi; Nigel H Russell; Francesco Lo-Coco
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

2.  Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.

Authors:  Mark P Labrecque; Ilsa M Coleman; Lisha G Brown; Lawrence D True; Lori Kollath; Bryce Lakely; Holly M Nguyen; Yu C Yang; Rui M Gil da Costa; Arja Kaipainen; Roger Coleman; Celestia S Higano; Evan Y Yu; Heather H Cheng; Elahe A Mostaghel; Bruce Montgomery; Michael T Schweizer; Andrew C Hsieh; Daniel W Lin; Eva Corey; Peter S Nelson; Colm Morrissey
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

3.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.

Authors:  Himisha Beltran; Clara Oromendia; Daniel C Danila; Bruce Montgomery; Christopher Hoimes; Russell Z Szmulewitz; Ulka Vaishampayan; Andrew J Armstrong; Mark Stein; Jacek Pinski; Juan M Mosquera; Verena Sailer; Rohan Bareja; Alessandro Romanel; Naveen Gumpeni; Andrea Sboner; Etienne Dardenne; Loredana Puca; Davide Prandi; Mark A Rubin; Howard I Scher; David S Rickman; Francesca Demichelis; David M Nanus; Karla V Ballman; Scott T Tagawa
Journal:  Clin Cancer Res       Date:  2018-09-19       Impact factor: 12.531

4.  Challenges in recognizing treatment-related neuroendocrine prostate cancer.

Authors:  Himisha Beltran; Scott T Tagawa; Kyung Park; Theresa MacDonald; Matthew I Milowsky; Juan Miguel Mosquera; Mark A Rubin; David M Nanus
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

5.  Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.

Authors:  Himisha Beltran; David S Rickman; Kyung Park; Sung Suk Chae; Andrea Sboner; Theresa Y MacDonald; Yuwei Wang; Karen L Sheikh; Stéphane Terry; Scott T Tagawa; Rajiv Dhir; Joel B Nelson; Alexandre de la Taille; Yves Allory; Mark B Gerstein; Sven Perner; Kenneth J Pienta; Arul M Chinnaiyan; Yuzhuo Wang; Colin C Collins; Martin E Gleave; Francesca Demichelis; David M Nanus; Mark A Rubin
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

6.  Poly (ADP-Ribose) Polymerase Inhibitors for De Novo BRCA2-Null Small-Cell Prostate Cancer.

Authors:  Brice Chanez; Max Chaffanet; José Adélaide; Jeanne Thomassin; Séverine Garnier; Nadine Carbuccia; Arnaud Guille; Nathalie Charrier; Isabelle Brenot-Rossi; Jochen Walz; Géraldine Pignot; Jihane Pakradouni; Anthony Gonçalvès; François Eisinger; François Bertucci; Daniel Birnbaum; Gwenaëlle Gravis
Journal:  JCO Precis Oncol       Date:  2018-11

7.  Understanding the lethal variant of prostate cancer: power of examining extremes.

Authors:  Ana Aparicio; Christopher J Logothetis; Sankar N Maity
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

8.  Targeting DNA repair defects in prostate cancer.

Authors:  Clemens Thoma
Journal:  Nat Rev Urol       Date:  2020-08       Impact factor: 14.432

9.  Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.

Authors:  Himisha Beltran; Davide Prandi; Juan Miguel Mosquera; Matteo Benelli; Loredana Puca; Joanna Cyrta; Clarisse Marotz; Eugenia Giannopoulou; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally; Scott A Tomlins; David M Nanus; Scott T Tagawa; Eliezer M Van Allen; Olivier Elemento; Andrea Sboner; Levi A Garraway; Mark A Rubin; Francesca Demichelis
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

10.  Improving performance of multigene panels for genomic analysis of cancer predisposition.

Authors:  Brian H Shirts; Silvia Casadei; Angela L Jacobson; Ming K Lee; Suleyman Gulsuner; Robin L Bennett; Margaret Miller; Sarah A Hall; Heather Hampel; Fuki M Hisama; Lorraine V Naylor; Cathleen Goetsch; Kathleen Leppig; Jonathan F Tait; Sheena M Scroggins; Emily H Turner; Robert Livingston; Stephen J Salipante; Mary-Claire King; Tom Walsh; Colin C Pritchard
Journal:  Genet Med       Date:  2016-02-04       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.